Edgley AJ, Tare M, Evans RG, Skordilis C, Parkington HC. In vivo regulation of endothelium-dependent vasodilation in the rat renal circulation and the effect of streptozotocin-induced diabetes. Am J Physiol Regul Integr Comp Physiol 295: R829 -R839, 2008. First published July 16, 2008 doi:10.1152/ajpregu.00861.2007.-We assessed the relative contributions of endothelium-derived relaxing factors to renal vasodilation in vivo and determined whether these are altered in established streptozotocin-induced diabetes. In nondiabetic rats, stimulation of the endothelium by locally administered ACh or bradykinin-induced transient renal hyperemia. Neither basal renal blood flow (RBF) nor renal hyperemic responses to ACh or bradykinin were altered by blockade of prostanoid production (indomethacin) or by administration of charybdotoxin (ChTx) plus apamin to block endothelium-derived hyperpolarizing factor (EDHF). In contrast, combined blockade of nitric oxide (NO) synthase, N -nitro-L-arginine methyl ester (L-NAME), and prostanoid production reduced basal RBF and the duration of the hyperemic responses to ACh and bradykinin and revealed a delayed ischemic response to ACh. Accordingly, L-NAME and indomethacin markedly reduced integrated (area under the curve) hyperemic responses to ACh and bradykinin. Peak increases in RBF in response to ACh and bradykinin were not reduced by L-NAME and indomethacin but were reduced by subsequent blockade of EDHF. L-NAME plus indomethacin and ChTx plus apamin altered RBF responses to endothelium stimulation in a qualitatively similar fashion in diabetic and nondiabetic rats. The integrated renal hyperemic responses to ACh and bradykinin were blunted in diabetes, due to a diminished contribution of the component abolished by L-NAME plus indomethacin. We conclude that NO dominates integrated hyperemic responses to ACh and bradykinin in the rat kidney in vivo. After prior inhibition of NO synthase, EDHF mediates transient renal vasodilation in vivo. Renal endotheliumdependent vasodilation is diminished in diabetes due to impaired NO function. kidney circulation; acetylcholine; bradykinin; endothelium-derived hyperpolarizing factor; nitric oxide THE VASCULAR ENDOTHELIUM MEDIATES relaxation of the underlying smooth muscle via the actions of several vasodilators, including nitric oxide (NO), prostanoids (e.g., prostacyclin), and an endothelium-derived hyperpolarizing factor (EDHF) (36). The relative importance of these vasodilators varies across different vascular beds (32). While NO is critical in the larger vessels, EDHF assumes greater importance in smallresistance arteries (34).Endothelium-derived NO, prostanoids, and EDHF have all been implicated in the control of renal vascular tone in vitro. Inhibition of NO synthase (NOS) significantly reduces endothelium-dependent vasodilation in the renal bed, with an additional role of prostanoid revealed by inhibition of cyclooxygenase (COX) (30). Following inhibition of NOS and COX, there remains a vasodilator response to endothelial stimulation by A...